Results from the iDose TR exchange trial showed a second administration and removal of the original implant was safe and well tolerated over 12 months.

Litifilimab is a humanized IgG1 monoclonal antibody targeting the BDCA2 receptor to reduce proinflammatory mediators in cutaneous lupus erythematosus.

An AAV vector genome integration event associated with PLAG1 overexpression was identified in a preliminary analysis of the resected tumor.

Darzalex Faspro is a subcutaneous formulation that combines daratumumab, a CD38-directed cytolytic antibody, and hyaluronidase, an endoglycosidase.

Spring & Mulberry announced January 14 that it has expanded its voluntary recall to include several additional chocolate flavors. The Raleigh, North Carolina–based company said the products may ...

Many pediatricians are following vaccine guidance from the American Academy of Pediatrics, not the US Centers for Disease Control and Prevention ...

HealthDay News — For the 5 leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...

Vaccination linked to lower inflammation scores, slower epigenetic, transcriptomic aging, and a lower composite biological aging score.